Pages that link to "Q33899433"
Jump to navigation
Jump to search
The following pages link to Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial (Q33899433):
Displaying 50 items.
- Protocol of a randomised phase III clinical trial of sequential capecitabine or 5-fluorouracil plus bevacizumab (Cape/5-FU-Bmab) to capecitabine or 5-fluorouracil plus oxaliplatin plus bevacizumab (CapeOX/mFOLFOX6-Bmab) .. (Q24658529) (← links)
- The impact of comorbidity on cancer and its treatment (Q26764935) (← links)
- Geriatric oncology: problems with under-treatment within this population (Q26771401) (← links)
- Treatment of colorectal cancer in the elderly (Q26781457) (← links)
- Management of locally advanced and metastatic colon cancer in elderly patients (Q27026129) (← links)
- How to select the optimal treatment for first line metastatic colorectal cancer (Q27026516) (← links)
- Can we predict toxicity and efficacy in older patients with cancer? Older patients with colorectal cancer as an example (Q28069620) (← links)
- Decision-making in geriatric oncology: systemic treatment considerations for older adults with colon cancer (Q30244769) (← links)
- Improving the quality of survivorship for older adults with cancer (Q30250334) (← links)
- Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database (Q31136880) (← links)
- Comparison of toxicity profiles of fluorouracil versus oxaliplatin regimens in a large population-based cohort of elderly patients with colorectal cancer (Q33397780) (← links)
- Relative effectiveness and safety of chemotherapy in elderly and nonelderly patients with stage III colon cancer: a systematic review. (Q33405177) (← links)
- Strategies of sequential therapies in unresectable metastatic colorectal cancer: a meta-analysis (Q33419230) (← links)
- Prognostic relevance of KRAS genotype in metastatic colorectal cancer patients unfit for FIr-B/FOx intensive regimen (Q33778129) (← links)
- The effect of geriatric intervention in frail elderly patients receiving chemotherapy for colorectal cancer: a randomized trial (GERICO). (Q33851067) (← links)
- Senior adult oncology: three cases of advanced cancer in patients of advanced age (Q33928825) (← links)
- Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations (Q34031134) (← links)
- Determining chemotherapy tolerance in older patients with cancer (Q34155010) (← links)
- The Role of Capecitabine in Locally Advanced Rectal Cancer Treatment (Q34276823) (← links)
- Bevacizumab in first-line treatment of elderly patients with metastatic colorectal cancer: German community-based observational cohort study results (Q34347083) (← links)
- The outcome of self-expanding metal stents in elderly patients (Q34401231) (← links)
- A retrospective cohort study of patients with stomach and liver cancers: the impact of comorbidity and ethnicity on cancer care and outcomes (Q34517306) (← links)
- Capecitabine and bevacizumab for non-resectable metastatic colorectal cancer patients: final results from phase II AIO KRK 0105 trial (Q35007200) (← links)
- Capecitabine in combination with oxaliplatin and bevacizumab (AXELOX) as 1st line treatment for fit and vulnerable elderly patients (aged >70 years) with metastatic colorectal cancer (mCRC): a multicenter phase II study of the Hellenic Oncology Rese (Q35154728) (← links)
- Assessing the benefit-risk of new treatments using generalised pairwise comparisons: the case of erlotinib in pancreatic cancer (Q35198343) (← links)
- Chemotherapy for colorectal cancer in the elderly (Q35567604) (← links)
- On-going clinical trials for elderly patients with a hematological malignancy: are we addressing the right end points? (Q35611941) (← links)
- Comparing the effectiveness of capecitabine versus 5-fluorouracil/leucovorin therapy for elderly Taiwanese stage III colorectal cancer patients based on quality-of-life measures (QLQ-C30 and QLQ-CR38) and a new cost assessment tool. (Q35663058) (← links)
- Predictors of chemotherapy dose reduction at first cycle in patients age 65 years and older with solid tumors (Q35771257) (← links)
- Capecitabine and oxaliplatin combined with bevacizumab are feasible for treating selected Japanese patients at least 75 years of age with metastatic colorectal cancer. (Q35819857) (← links)
- Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints Database (Q35917852) (← links)
- Capecitabine in the routine first-line treatment of elderly patients with advanced colorectal cancer--results from a non-interventional observation study. (Q35920292) (← links)
- Integrating patient reported measures as predictive parameters into decisionmaking about palliative chemotherapy: a pilot study. (Q38630367) (← links)
- Palliative chemotherapy for patients 70 years of age and older with metastatic colorectal cancer: a single-centre experience (Q36169867) (← links)
- Geriatric Assessment-Guided Care Processes for Older Adults: A Delphi Consensus of Geriatric Oncology Experts. (Q36242685) (← links)
- Efficacy of FOLFOXIRI versus XELOXIRI plus bevacizumab in the treatment of metastatic colorectal cancer (Q36411962) (← links)
- SGO guidance document for clinical trial designs in ovarian cancer: a changing paradigm (Q36424039) (← links)
- Pharmacokinetics of Selected Anticancer Drugs in Elderly Cancer Patients: Focus on Breast Cancer (Q36506987) (← links)
- A prospective study of XELOX plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer (KSCC 0902). (Q36778075) (← links)
- Senior adult oncology (Q36851424) (← links)
- Palliative chemotherapy in advanced colorectal cancer patients 80 years of age and older (Q36989058) (← links)
- Patterns of care and outcomes of older versus younger patients with metastatic pancreatic cancer: A Fox Chase Cancer Center experience (Q37038460) (← links)
- Geriatric oncology research to improve clinical care (Q37082755) (← links)
- Folfirinox in elderly patients with pancreatic or colorectal cancer-tolerance and efficacy (Q37411495) (← links)
- Challenges in the Management of Older Patients With Colon Cancer (Q37598467) (← links)
- Clinico-Pathological Caracteristics, Therapeutic Features and Post-operative Course of Colorectal Cancer in Elderly Patients (Q37612039) (← links)
- Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (Q37647279) (← links)
- An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma (Q37696246) (← links)
- Treatment of older patients with colorectal cancer: a perspective review (Q37704350) (← links)
- The treatment of patients with low tumour burden and/or slow growing disease (Q37937933) (← links)